Literature DB >> 22274728

For whom should we use selective decontamination of the digestive tract?

Anne Marie G A de Smet1, Marc J M Bonten, Jan A J W Kluytmans.   

Abstract

PURPOSE OF REVIEW: This review discusses the relevant studies on selective decontamination of the digestive tract (SDD) published between 2009 and mid-2011. RECENT
FINDINGS: In a multicenter cluster-randomized cross-over study in the Netherlands, SDD and selective oropharyngeal decontamination (SOD) were associated with higher survival at day 28, with a lower incidence of ICU-acquired bacteremia and with less acquisition of respiratory tract colonization with antibiotic resistant pathogens, compared to standard care. A post-hoc analysis of this study suggests that SDD might be more effective in surgical patients and SOD in nonsurgical patients. In a randomized study perioperative use of SDD in patients undergoing gastrointestinal surgery was associated with lower incidences of anastomotic leakages. A Cochrane meta-analysis, not including any of the before mentioned studies, reported a reduction of respiratory tract infections in studies by using topical antibiotics only and higher survival rates when topical antibiotics were combined with parenteral antibiotics.
SUMMARY: Recent studies show that in ICUs with low levels of antibiotic resistance, SDD and SOD improved patient outcome and reduced infections and carriage with antibiotic-resistant pathogens. The effect in settings with higher levels of antibiotic resistance remains to be determined as well as the efficacy of SDD and SOD in specific patient groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274728     DOI: 10.1097/QCO.0b013e3283507f8c

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  4 in total

Review 1.  Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis.

Authors:  Richard Price; Graeme MacLennan; John Glen
Journal:  BMJ       Date:  2014-03-31

Review 2.  Gut failure in critical care: old school versus new school.

Authors:  Eleni Sertaridou; Vasilios Papaioannou; George Kolios; Ioannis Pneumatikos
Journal:  Ann Gastroenterol       Date:  2015 Jul-Sep

3.  Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study.

Authors:  Estelle Peronnet; Fabienne Venet; Delphine Maucort-Boulch; Arnaud Friggeri; Martin Cour; Laurent Argaud; Bernard Allaouchiche; Bernard Floccard; Frédéric Aubrun; Thomas Rimmelé; Fabrice Thiolliere; Vincent Piriou; Julien Bohé; Marie-Angélique Cazalis; Véronique Barbalat; Guillaume Monneret; Stéphane Morisset; Julien Textoris; Hélène Vallin; Alexandre Pachot; Alain Lepape
Journal:  Intensive Care Med       Date:  2017-05-05       Impact factor: 17.440

4.  High throughput cultivation-based screening on porous aluminum oxide chips allows targeted isolation of antibiotic resistant human gut bacteria.

Authors:  Dennis Versluis; Teresita de J Bello González; Erwin G Zoetendal; Mark W J van Passel; Hauke Smidt
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.